Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Current Assets (2016 - 2025)

Bio-Techne (TECH) has 16 years of Current Assets data on record, last reported at $637.4 million in Q4 2025.

  • For Q4 2025, Current Assets changed 0.44% year-over-year to $637.4 million; the TTM value through Dec 2025 reached $637.4 million, changed 0.44%, while the annual FY2025 figure was $608.3 million, 1.48% down from the prior year.
  • Current Assets reached $637.4 million in Q4 2025 per TECH's latest filing, up from $609.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $648.6 million in Q3 2024 and bottomed at $510.6 million in Q2 2021.
  • Average Current Assets over 5 years is $594.8 million, with a median of $599.3 million recorded in 2022.
  • Peak YoY movement for Current Assets: grew 18.6% in 2022, then decreased 6.02% in 2025.
  • A 5-year view of Current Assets shows it stood at $590.2 million in 2021, then decreased by 4.24% to $565.2 million in 2022, then grew by 4.5% to $590.6 million in 2023, then increased by 7.45% to $634.6 million in 2024, then increased by 0.44% to $637.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $637.4 million in Q4 2025, $609.5 million in Q3 2025, and $608.3 million in Q2 2025.